| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.064 | 0.2 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.2 |